Signaturefd LLC Has $440,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Signaturefd LLC boosted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 19.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 16,843 shares of the pharmacy operator’s stock after buying an additional 2,800 shares during the quarter. Signaturefd LLC’s holdings in Walgreens Boots Alliance were worth $440,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. CWM LLC increased its position in shares of Walgreens Boots Alliance by 53.2% during the 3rd quarter. CWM LLC now owns 33,393 shares of the pharmacy operator’s stock worth $743,000 after purchasing an additional 11,602 shares during the last quarter. HB Wealth Management LLC increased its position in shares of Walgreens Boots Alliance by 48.5% during the 3rd quarter. HB Wealth Management LLC now owns 11,019 shares of the pharmacy operator’s stock worth $245,000 after purchasing an additional 3,598 shares during the last quarter. Impact Partnership Wealth LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $133,000. Exchange Traded Concepts LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $398,000. Finally, Hennessy Advisors Inc. increased its holdings in shares of Walgreens Boots Alliance by 1.7% during the 3rd quarter. Hennessy Advisors Inc. now owns 124,250 shares of the pharmacy operator’s stock worth $2,763,000 after acquiring an additional 2,050 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $17.81 on Thursday. The stock has a fifty day moving average price of $20.19 and a 200-day moving average price of $21.84. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a fifty-two week low of $17.51 and a fifty-two week high of $35.54.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.16 EPS. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Insider Activity

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Manmohan Mahajan purchased 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. In the last three months, insiders purchased 13,456 shares of company stock worth $270,423. 17.40% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms recently weighed in on WBA. Barclays began coverage on Walgreens Boots Alliance in a report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 target price on the stock. Deutsche Bank Aktiengesellschaft decreased their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a report on Wednesday, April 3rd. UBS Group decreased their target price on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, April 3rd. Truist Financial reissued a “hold” rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Finally, Morgan Stanley decreased their target price on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a report on Monday, April 1st. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $24.36.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.